Abstract

The present disclosure relates to a process for the preparation of (2E,16E)-11-[2­(pyrrolidin-1-yl)ethoxy]-14,19-dioxa-5,7,27-triazatetracyclo [19.3.1.1(2,6). 1 (8,12)]heptacosa-1(25),2,4,6,8,10,12(26),16,21,23-decaene of formula-1 and its intermediates. The Compound of formula-1 is represented by the following structural formula.

Formula-1.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

Share

COinS